<?xml encoding="utf-8" ?> AbbVie ABBV reported third-quarter financial results on Friday. The transcript from the company’s ...

AbbVie reported third-quarter 2026 adjusted EPS of $3.82, $0.07 above the guidance midpoint, on net revenues of $17.4 billion ...

Scroll through Instagram on any given Tuesday, and you are bound to hit the "Glow Up" algorithm. With the dramatic ...

Gleam Premium Derma Clinic is inviting franchise partners to establish premium dermatology and aesthetic clinics, with a proposed investment of ₹1 crore, a 1,000–1,500 sq. ft. clinic format and an ...

Clint Eastwood, 96, on the United States: "It's not like in Europe, there aren't many independent art forms here" Celebrities ...

Michael Saul heads TJL Solicitors’ cosmetic surgery negligence department, the first of its kind dedicated to helping victims ...

Recognized for her work in public awareness and her business career, she advocates an approach to health that prioritizes scientific rigor, continuous professional development, and personalized care.

California doctor Violetta Mailyan was sentenced to 15 years in prison for running what federal officials call the largest ...

Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Third Quarter 2026 Earnings Conference Call.

AbbVie Inc (ABBV) beat revenue expectations with $17.4 billion in Q3 2026, lifted full-year guidance on SKYRIZI and RINVOQ strength, and raised its quarterly dividend 5.2%.